Physician’s Briefing Weekly Coronavirus Roundup
U.S. COVID-19 Vaccine Distribution Could Begin in Mid-December
Vaccine appears 95 percent effective at preventing mild-to-severe COVID-19, according to the manufacturers
Delirium Common in Seniors Presenting to ED With COVID-19
Delirium is the sixth most common presenting symptom/sign; delirium linked to ICU stay and death
AHA: Obese Patients More Likely to Be Hospitalized for COVID-19
Risk for in-hospital death, mechanical ventilation higher for obese patients; link between BMI and outcomes strongest for adults ≥50 years
SARS-CoV-2 Infection Rates Generally Low in U.S. Children
Black, Hispanic, Asian children less likely to get tested for SARS-CoV-2, more likely to test positive than White children
BCG Vaccination Linked to Lower SARS-CoV-2 Seroprevalence
Seroprevalence of anti-SARS-CoV-2 IgG lower for health care workers with history of BCG vaccination
Non-COVID-19-Related Deaths Up, Too
Excess deaths seen for specific gender and age groups, with protective effect seen for female children
Chimpanzee Adenovirus COVID-19 Vaccine Promising in Seniors
Immunogenicity similar across age groups; vaccine better tolerated in older versus younger adults
WHO: Remdesivir Not Advised for Hospitalized COVID-19 Patients
Evidence to date has not shown clinically important effects on mortality, need for mechanical ventilation
Third COVID-19 Vaccine Shows Effectiveness
The AstraZeneca vaccine becomes the third to show good effectiveness
